Search
Descriptor English: Antidepressive Agents, Tricyclic
Descriptor Spanish: Antidepresivos Tricíclicos
Descriptor Portuguese: Antidepressivos Tricíclicos
Descriptor French: Antidépresseurs tricycliques
Entry term(s): Agent, Tricyclic Antidepressive
Agents, Tricyclic Antidepressive
Antidepressant Drug, Tricyclic
Antidepressant Drugs, Tricyclic
Antidepressant, Tricyclic
Antidepressants, Tricyclic
Antidepressive Agent, Tricyclic
Drug, Tricyclic Antidepressant
Drugs, Tricyclic Antidepressant
Tricyclic Antidepressant
Tricyclic Antidepressant Drug
Tricyclic Antidepressant Drugs
Tricyclic Antidepressants
Tricyclic Antidepressive Agent
Tricyclic Antidepressive Agents
Tree number(s): D27.505.954.427.700.122.055
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000929
Scope note: Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Antidepressive Agents (1968-1974)
Public MeSH Note: 75
History Note: 75
DeCS ID: 936
Unique ID: D000929
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1975/09/01
Date of Entry: 1974/11/11
Revision Date: 2020/05/27
Antidepressive Agents, Tricyclic - Preferred
Concept UI M0001387
Scope note Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
Preferred term Antidepressive Agents, Tricyclic
Entry term(s) Agent, Tricyclic Antidepressive
Agents, Tricyclic Antidepressive
Antidepressant Drug, Tricyclic
Antidepressant Drugs, Tricyclic
Antidepressant, Tricyclic
Antidepressants, Tricyclic
Antidepressive Agent, Tricyclic
Drug, Tricyclic Antidepressant
Drugs, Tricyclic Antidepressant
Tricyclic Antidepressant
Tricyclic Antidepressant Drug
Tricyclic Antidepressant Drugs
Tricyclic Antidepressants
Tricyclic Antidepressive Agent
Tricyclic Antidepressive Agents



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey